AUG 02, 2016 5:32 AM PDT

‘Kissing Disease' Virus Now Linked to Breast Cancer

WRITTEN BY: Xuan Pham

One of the most common viruses in the world – and one of the few that’s actually shown to cause cancer – has now been linked to a new cancer type: breast cancer. Indeed, more than 90 percent of the world’s population is infected with the Epstein-Barr virus (EBV), and mounting evidence suggests this viral infection is anything but benign.
 
Epstein-Barr virus | Image: Albert Eistein College of MedicineSince its discovery in the 1960s, the Epstein-Barr virus has proven to be increasingly more complex. Also called human herpesvirus 4 (HHV-4), EBV is one of eight viruses in the herpes family. It’s infamous for causing “the kissing disease,” otherwise known as mono (short for mononucleosis), in teenagers.
 
But even more threatening than causing swollen lymph glands and fevers, EBV was the first virus shown to cause cancer directly. In particular, EBV infection is linked to two types of lymphomas (Burkitt’s and Hodgkin’s), stomach cancer, and some types of head and neck cancer (nasopharyngeal carcinoma). Some scientists have suspected EBV may also cause cancer of the breast, but the evidence hasn’t been causal – until now.
 
Working with breast cells called primary mammary epithelial cells (MECs), researchers at the Beth Israel Deaconess Medical Center (BIDMC) sought out to study whether EBV could influence the fate of these cells. Indeed, when the MECs were exposed to EBV, the cells transformed into a stem-cell-like state, which allowed them to proliferate without control. This is the first sign that the cells have turned down a cancerous path.
 
Then, when those cells were transplanted into mice, breast tumors formed. This is the second – and quite convincing evidence, showing that EBV turned normal cells into cancer-prone cells.
 
When the team examined the profile of the infected cells, they found changes similar to those of high-grade, estrogen-receptor-negative breast tumors. This line of evidence reinforce the strength of the virus to wreak havoc in the body.
 


"We think that if a young woman develops EBV during her teenage years or later, her breast epithelial cells will be exposed to the virus and can be infected. While for most individuals, there will be no long-term consequences, in some the infection may leave genetic scars and change the metabolism of these cells," said Gerburg Wulf, physician scientist at the BIDMC, and senior study investigator. "While these are subtle changes, they may, decades later, facilitate breast cancer formation."
 
But there’s a silver lining from this discovery, and it may come in the form of a vaccine. "The findings further make the case for an EBV vaccine that might protect children from infection and later EBV-associated malignancies," said Wulf. Scientists are currently testing a few EBV protein targets for vaccine discovery, however, the virus is complex and no vaccines are available as of yet.

Additional source: BIDMC press release
 

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 29, 2019
Cancer
NOV 29, 2019
How flavonoids fight against colorectal cancer
New research published in the journal Cancers reports why flavonoids can aid in reducing the risk of colorectal cancer. Flavonoids are compounds found in f...
DEC 08, 2019
Cancer
DEC 08, 2019
Is there an association between smoking marijuana and cancer?
The controversy with marijuana is only likely to continue as research studies try to understand if marijuana use is associated to an increased risk of canc...
DEC 08, 2019
Cancer
DEC 08, 2019
Why do colder, wetter climates have a higher prevalence of cancer?
You might want to sit down, because this news may come as a surprise: researchers have found an association between cold, wet climates and increased cancer...
JAN 07, 2020
Immunology
JAN 07, 2020
"Good" T Cells Can Go "Bad," But in the Case of Cancer, That's A Good Thing
T cells may be able to reach their full potential in the fight against cancer with a little nudge. In 2010, scientists first observed CD4+ T cells transiti...
FEB 23, 2020
Cancer
FEB 23, 2020
Celular aging reexamined
New research published in Genes and Development has identified one of the mysteries of aging. According to scientists at Sanford Burnham Prebys Medical Dis...
FEB 19, 2020
Technology
FEB 19, 2020
Novel Technology Analyzes Single Cancer Cells
Recent technology may help for the first time to enable cancer scientists the analysis of individual behavior of millions of different cells living inside ...
Loading Comments...